Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria
- PMID: 38838320
- DOI: 10.1056/NEJMc2404445
Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria
Comment on
-
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria.N Engl J Med. 2024 Mar 14;390(11):994-1008. doi: 10.1056/NEJMoa2308695. N Engl J Med. 2024. PMID: 38477987
Similar articles
-
Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria.N Engl J Med. 2024 Jun 6;390(21):2032-2033. doi: 10.1056/NEJMc2404445. N Engl J Med. 2024. PMID: 38838319 No abstract available.
-
Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria. Reply.N Engl J Med. 2024 Jun 6;390(21):2033-2034. doi: 10.1056/NEJMc2404445. N Engl J Med. 2024. PMID: 38838321 No abstract available.
-
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial.Lancet Haematol. 2021 May;8(5):e344-e354. doi: 10.1016/S2352-3026(21)00028-4. Epub 2021 Mar 23. Lancet Haematol. 2021. PMID: 33765419 Clinical Trial.
-
Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria.Blood Rev. 2024 Jul;66:101210. doi: 10.1016/j.blre.2024.101210. Epub 2024 May 25. Blood Rev. 2024. PMID: 38811284 Review.
-
Iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria.Expert Opin Pharmacother. 2024 Dec;25(18):2331-2339. doi: 10.1080/14656566.2024.2404110. Epub 2024 Oct 15. Expert Opin Pharmacother. 2024. PMID: 39404123 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources